Form D — Starget Pharma Inc.
0002108969-26-000001 · filed 2026-02-03
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $22,158,515
- Total sold
- $16,373,737
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Starget Pharma Inc.
- CIK
- 2108969
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 2031 KINGS HIGHWAY
SHREVEPORT, LA 71103 - Phone
- 318-746-8430
Related persons
-
Sigal Kalmanson Cusnir · Executive OfficerTzofit, L3
-
Ronen Kalmanson · DirectorRamat Hasharon, L3
View original on SEC EDGAR.